Page 100 - GALENIKA MEDICAL JOURNAL
P. 100

Abstract
          Incidence of diabetes in childhood is rising, and Serbia is the country with high incidence of diabetes. Establishing the
          diagnosis early, in the presymptomatic phase, provides the opportunity to educate the family and prevent diabetic
          ketoacidosis, but also enables the administration of the innovative treatment for potential delay of the development of
          the established diabetes. New insulins preparation and advanced diabetes technologies are discussed in new guidelines of
          International society for pediatric and adolescent diabetes.

          Keywords: diabetes type 1, children, prevention, insulin treatment





          Literatura                                         16.  Geographic patterns of childhood insulin-dependent diabetes mellitus.
                                                                Diabetes Epidemiology Research International Group. Diabetes. 1988
                                                                Aug;37(8):1113-9.
          1.  American Diabetes Association Professional Practice Committee. 2.   17.  Lévy-Marchal C, Patterson CC, Green A; EURODIAB ACE Study Group.
             Classification and Diagnosis of Diabetes: Standards of Medical Care in   Europe and Diabetes. Geographical variation of presentation at
             Diabetes-2022. Diabetes Care. 2022 Jan 1;45(Suppl 1):S17-S38.   diagnosis of type I diabetes in children: the EURODIAB study. European
          2.  Besser REJ, Bell KJ, Couper JJ, Ziegler AG, Wherrett DK, Knip M, et   and Dibetes. Diabetologia. 2001 Oct;44 Suppl 3:B75-80.
             al. ISPAD Clinical Practice Consensus Guidelines 2022: Stages of   18.  Incidencija i mortalitet od dijabetesa u Srbiji. Registar za dijabetes 2021.
             type 1 diabetes in children and adolescents. Pediatr Diabetes. 2022   Institut za javno zdravlje dr Milan Jovanović Batut. www.batut.org.rs
             Dec;23(8):1175-87.
                                                             19.  Gale EA. The rise of childhood type 1 diabetes in the 20th century.
          3.  Sims EK, Besser REJ, Dayan C, Geno Rasmussen C, Greenbaum C,   Diabetes. 2002 Dec;51(12):3353-61.
             Griffin KJ, et al; NIDDK Type 1 Diabetes TrialNet Study Group. Screening
             for Type 1 Diabetes in the General Population: A Status Report and   20.  Sherr JL, Schoelwer M, Dos Santos TJ, Reddy L, Biester T, Galderisi A,
             Perspective. Diabetes. 2022 Apr 1;71(4):610-23.    et al. ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes
          4.  Winkler C, Schober E, Ziegler AG, Holl RW. Markedly reduced rate of   technologies: Insulin delivery. Pediatr Diabetes. 2022 Dec;23(8):1406-31.
             diabetic ketoacidosis at onset of type 1 diabetes in relatives screened   21.  Cengiz E, Danne T, Ahmad T, Ayyavoo A, Beran D, Ehtisham S, et al.
             for islet autoantibodies. Pediatr Diabetes. 2012 Jun;13(4):308-13.  ISPAD Clinical Practice Consensus Guidelines 2022: Insulin treatment
                                                                in children and adolescents with diabetes. Pediatr Diabetes. 2022
          5.  Ziegler AG, Rewers M, Simell O, Simell T, Lempainen J, Steck A, et al.   Dec;23(8):1277-96.
             Seroconversion to multiple islet autoantibodies and risk of progression
             to diabetes in children. JAMA. 2013 Jun 19;309(23):2473-9.   22.  Gregory JW, Cameron FJ, Joshi K, Eiswirth M, Garrett C, Garvey K, et
          6.  Krischer JP, Lynch KF, Schatz DA, Ilonen J, Lernmark Å, Hagopian WA,   al. ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes in
                                                                adolescence. Pediatr Diabetes. 2022 Nov;23(7):857-71.
             et al; TEDDY Study Group. The 6 year incidence of diabetes-associated
             autoantibodies in genetically at-risk children: the TEDDY study.   23.  Thalange N, Deeb L, Iotova V, Kawamura T, Klingensmith G, Philotheou
             Diabetologia. 2015 May;58(5):980-7.                A, et al. Insulin degludec in combination with bolus insulin aspart is
          7.  Bingley PJ, Boulware DC, Krischer JP; Type 1 Diabetes TrialNet Study   safe and effective in children and adolescents with type 1 diabetes.
                                                                Pediatr Diabetes. 2015 May;16(3):164-76.
             Group. The implications of autoantibodies to a single islet antigen
             in relatives with normal glucose tolerance: development of other   24.  Greenbaum CJ. A Key to T1D Prevention: Screening and Monitoring
             autoantibodies and progression to type 1 diabetes. Diabetologia. 2016   Relatives as Part of Clinical Care. Diabetes. 2021 May;70(5):1029-37.
             Mar;59(3):542-9.
                                                             25.  Ziegler AG, Danne T, Dunger DB, Berner R, Puff R, Kiess W, et al.
          8.  Nguyen C, Varney MD, Harrison LC, Morahan G. Definition of high-risk   Primary prevention of beta-cell autoimmunity and type 1 diabetes - The
             type 1 diabetes HLA-DR and HLA-DQ types using only three single   Global Platform for the Prevention of Autoimmune Diabetes (GPPAD)
             nucleotide polymorphisms. Diabetes. 2013 Jun;62(6):2135-40.  perspectives. Mol Metab. 2016 Feb 22;5(4):255-62.
          9.  Anand V, Li Y, Liu B, Ghalwash M, Koski E, Ng K, et al; T1DI Study   26.  Herold KC, Bundy BN, Long SA, Bluestone JA, DiMeglio LA, Dufort MJ,
             Group. Islet Autoimmunity and HLA Markers of Presymptomatic and   et al; Type 1 Diabetes TrialNet Study Group. An Anti-CD3 Antibody,
             Clinical Type 1 Diabetes: Joint Analyses of Prospective Cohort Studies   Teplizumab, in Relatives at Risk for Type 1 Diabetes. N Engl J Med. 2019
             in Finland, Germany, Sweden, and the U.S. Diabetes Care. 2021 Jun   Aug 15;381(7):603-613.
             23;44(10):2269–76.
                                                             27.  Haller MJ, Schatz DA, Skyler JS, Krischer JP, Bundy BN, Miller JL,
          10.  Bonifacio E, Beyerlein A, Hippich M, Winkler C, Vehik K, Weedon MN,   et al; Type 1 Diabetes TrialNet ATG-GCSF Study Group. Low-Dose
             et al; TEDDY Study Group. Genetic scores to stratify risk of developing   Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and
             multiple islet autoantibodies and type 1 diabetes: A prospective study   Improves HbA1c in New-Onset Type 1 Diabetes. Diabetes Care. 2018
             in children. PLoS Med. 2018 Apr 3;15(4):e1002548.  Sep;41(9):1917-25.
          11.  Redondo MJ, Steck AK, Pugliese A. Genetics of type 1 diabetes. Pediatr
             Diabetes. 2018 May;19(3):346-53.
          12.  Krischer JP, Liu X, Lernmark Å, Hagopian WA, Rewers MJ, She JX, et   Konflikt interesa: Nema
             al; TEDDY Study Group. The Influence of Type 1 Diabetes Genetic
             Susceptibility Regions, Age, Sex, and Family History on the Progression   Primljeno: 22. 01. 2023.
             From Multiple Autoantibodies to Type 1 Diabetes: A TEDDY Study   Prihvaćeno: 20. 02. 2023.
             Report. Diabetes. 2017 Dec;66(12):3122-9.          Onlajn: 01. 03. 2023.
          13.  Viskari HR, Koskela P, Lönnrot M, Luonuansuu S, Reunanen A, Baer M,
             et al. Can enterovirus infections explain the increasing incidence of type
             1 diabetes? Diabetes Care. 2000 Mar;23(3):414-6.
          14.  Shah AS, Nadeau KJ. The changing face of paediatric diabetes.
             Diabetologia. 2020 Apr;63(4):683-91.
          15.  Ogle GD, James S, Dabelea D, Pihoker C, Svennson J, Maniam J, et
             al. Global estimates of incidence of type 1 diabetes in children and
             adolescents: Results from the International Diabetes Federation Atlas,
             10th edition. Diabetes Res Clin Pract. 2022 Jan;183:109083.



          98     DOI: 10.5937/Galmed2305096Z
   95   96   97   98   99   100   101   102   103   104   105